An update on glucocorticoid-induced osteoporosis
- PMID: 17551369
- DOI: 10.1097/BOR.0b013e328133f5c7
An update on glucocorticoid-induced osteoporosis
Abstract
Purpose of review: Glucocorticoids are widely used, often long term, and a major side effect is osteoporosis and increased risk of fracture. This review considers how common is the problem, the patients who are most at risk, our current understanding of mechanisms, and how to prevent and effectively treat glucocorticoid-induced osteoporosis. The actions currently being undertaken in clinical practice are reviewed.
Recent findings: Glucocorticoid-induced osteoporosis is an increasing problem that occurs not only in those on high-dose therapy. Advances in our knowledge of the cellular and cytokine mechanisms of bone turnover and glucocorticoid mechanisms of action are leading to a better understanding of how glucocorticoids affect bone cells and novel ways of prevention. Although there are effective treatments to prevent and control glucocorticoid-induced osteoporosis as well as guidelines for their use, they are still not being applied in routine clinical practice.
Summary: Glucocorticoid-induced osteoporosis is a significant problem. Although our understanding of effective prevention and treatment strategies is improving, there needs to be better implementation of these strategies.
Similar articles
-
Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.Minerva Med. 2008 Feb;99(1):23-43. Minerva Med. 2008. PMID: 18299694 Review.
-
Glucocorticoid-induced osteoporosis.Curr Opin Endocrinol Diabetes Obes. 2007 Dec;14(6):446-50. doi: 10.1097/MED.0b013e3282f15407. Curr Opin Endocrinol Diabetes Obes. 2007. PMID: 17982350 Review.
-
Glucocorticoid induced risk of fractures.Panminerva Med. 2010 Dec;52(4):339-43. Panminerva Med. 2010. PMID: 21183894 Review.
-
[Steroids as a risk factor for osteoporotic fracture].Clin Calcium. 2006 Nov;16(11):1797-1803. Clin Calcium. 2006. PMID: 17079845 Review. Japanese.
-
In whom and how to prevent glucocorticoid-induced osteoporosis.Best Pract Res Clin Rheumatol. 2005 Dec;19(6):1039-64. doi: 10.1016/j.berh.2005.07.002. Best Pract Res Clin Rheumatol. 2005. PMID: 16301196 Review.
Cited by
-
Dexamethasone-Activated MSCs Release MVs for Stimulating Osteogenic Response.Stem Cells Int. 2018 Apr 16;2018:7231739. doi: 10.1155/2018/7231739. eCollection 2018. Stem Cells Int. 2018. PMID: 29760734 Free PMC article.
-
Incidence of Symptomatic Vertebral Fractures Among Newly Diagnosed Autoimmune Diseases Initiating Glucocorticoid Therapy.Medicine (Baltimore). 2015 Jul;94(27):e875. doi: 10.1097/MD.0000000000000875. Medicine (Baltimore). 2015. PMID: 26166127 Free PMC article.
-
Hormone-Related and Drug-Induced Osteoporosis: A Cellular and Molecular Overview.Int J Mol Sci. 2023 Mar 18;24(6):5814. doi: 10.3390/ijms24065814. Int J Mol Sci. 2023. PMID: 36982891 Free PMC article. Review.
-
Impaired Bone Mineral Density in Pediatric Patients with Chronic Graft-versus-Host Disease.Biol Blood Marrow Transplant. 2018 Jul;24(7):1415-1423. doi: 10.1016/j.bbmt.2018.02.019. Epub 2018 Mar 1. Biol Blood Marrow Transplant. 2018. PMID: 29496562 Free PMC article.
-
Factors Associated with Non-Unions of Fifth Metatarsal Fractures.Arch Bone Jt Surg. 2025;13(6):367-377. doi: 10.22038/ABJS.2025.81228.3708. Arch Bone Jt Surg. 2025. PMID: 40641895 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials